UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1193-1199

2023

Volltextzugriff (PDF)

Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials

Journal of clinical oncology, 2013-01, Vol.31 (2), p.231-239

2013

Volltextzugriff (PDF)

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group

The lancet oncology, 2016-10, Vol.17 (10), p.1453-1462

2016

Volltextzugriff (PDF)

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Blood, 2010-09, Vol.116 (12), p.2026-2032

2010

Volltextzugriff (PDF)

Langzeitnachsorge nach Krebs - eine interdisziplinäre Aufgabe

Im Fokus Onkologie, 2020-02, Vol.23 (1), p.3-3

2020

Volltextzugriff (PDF)

The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma

Current hematologic malignancy reports, 2011-09, Vol.6 (3), p.164-171

2011

Volltextzugriff (PDF)

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group

Blood, 2014-03, Vol.123 (11), p.1658-1664

2014

Volltextzugriff (PDF)

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Journal of clinical oncology, 2016-12, Vol.34 (36), p.4329-4337

2016

Volltextzugriff (PDF)

Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.1753-1755

2022

Volltextzugriff (PDF)

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

Clinical research in cardiology, 2008-05, Vol.97 (5), p.318-326

2008

Volltextzugriff (PDF)

Kapitel 27 - Hodgkin-Lymphom

Therapie-Handbuch Onkologie und Hämatologie, 2022, p.190-194

Halbsguth, Teresa

2022

Volltextzugriff (PDF)

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

Blood, 2011-10, Vol.118 (16), p.4363-4365

2011

Volltextzugriff (PDF)

Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.6-7

2020

Volltextzugriff (PDF)

Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma

Blood, 2011-12, Vol.118 (24), p.6292-6298

2011

Volltextzugriff (PDF)

Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)

Blood, 2019-11, Vol.134 (Supplement_1), p.236-236

2019

Volltextzugriff (PDF)

Hodgkin’s Lymphoma in Adults

Deutsches Ärzteblatt international, 2013-03

2013

Volltextzugriff (PDF)

Kapitel 21 - Langzeitnachsorge

Therapie-Handbuch Onkologie und Hämatologie, 2022, p.146-150

2022

Volltextzugriff (PDF)

Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group

British journal of haematology, 2015-11, Vol.171 (4), p.547-556

2015

Volltextzugriff (PDF)

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up

Deutsches Ärzteblatt international, 2013-03, Vol.110 (11), p.177-183

2013

Volltextzugriff (PDF)

Interdisciplinary Evidence-Based Guideline for Diagnosis, Therapy and Follow-up of Adult Hodgkin Lymphoma Patients

Blood, 2012-11, Vol.120 (21), p.4230-4230

2012

Volltextzugriff (PDF)

Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG)

Blood, 2011-11, Vol.118 (21), p.432-432

2011

Volltextzugriff (PDF)

Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG)

Blood, 2011-11, Vol.118 (21), p.2711-2711

2011

Volltextzugriff (PDF)

Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol

Blood, 2010-11, Vol.116 (21), p.2682-2682

2010

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)
Buchkapitel
(8)

Sprache

Englisch
(27)
Deutsch
(10)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(17)
Journal Of Clinical Oncology
(3)
Deutsches Ärzteblatt International
(2)
The Lancet Oncology
(2)
British Journal Of Haematology
(1)
Clinical Research In Cardiology
(1)
Current Hematologic Malignancy Reports
(1)
Im Fokus Onkologie
(1)
Jama Oncology
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial

Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Langzeitnachsorge nach Krebs - eine interdisziplinäre Aufgabe

The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

Kapitel 27 - Hodgkin-Lymphom

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma

Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)

Hodgkin’s Lymphoma in Adults

Kapitel 21 - Langzeitnachsorge

Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up

Interdisciplinary Evidence-Based Guideline for Diagnosis, Therapy and Follow-up of Adult Hodgkin Lymphoma Patients

Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG)

Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG)

Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol

Suchergebnisse filtern